The £480 million contract awarded by NHS England to Palantir for its Federated Data Platform (FDP) has sparked fresh concerns over missed opportunities to boost the domestic health technology sector. The deal, touted as a revolutionary tool for consolidating patient data across the NHS, may have inadvertently handed a major contract to an overseas company at a time when the UK's own tech industry was ripe for growth.
The FDP aims to integrate various NHS data sources, providing healthcare professionals with more efficient access to comprehensive patient information. This integration could enhance operational planning, streamline patient pathways, and ultimately improve care delivery. For example, it might help manage waiting lists or track the spread of diseases with greater precision by connecting data from different NHS trusts and care settings.
Industry experts and UK health tech advocates have questioned whether the procurement process adequately considered the potential for UK-based companies to develop similar solutions or be significantly involved in delivering and developing the platform. This debate underscores a broader discussion about how major government contracts can be used to strengthen national industries and capabilities, aligning with the UK's ambition to lead in technology and innovation.
The review of the contract will likely scrutinise its value for money, strategic fit with NHS objectives, and long-term sustainability, including questions over who will retain control of critical infrastructure. A successful FDP could significantly enhance efficiency and patient outcomes, but these benefits must be weighed against concerns about the potential risks and limitations associated with outsourcing a major public sector investment to an international company.
According to sources, NHS England has stated that they are committed to ensuring the best possible value for taxpayers' money. The review is expected to explore how this commitment can be balanced with the need to support domestic innovation and jobs in the UK's burgeoning health technology sector.